Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 371 people who get email alerts on ACOR.

Get email alerts on ACOR »

Market Currents

Acorda Therapeutics (ACOR): Q3 EPS of $0.31 beats by $0.43. Revenue of $63.6M (+318%) vs....

Monday, November 1, 2010, 6:33 AM ET
Acorda Therapeutics (ACOR): Q3 EPS of $0.31 beats by $0.43. Revenue of $63.6M (+318%) vs. $52.2M. (PR)

This Market Current was sent to 371 people who get email alerts on ACOR.

Get email alerts on ACOR »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

Latest Articles

Hortons Hears A Hedge Fund
11:33 PM • Wealthcompound
Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability
11:06 PM • Jacob Smith
YCS Outperforms In A Yen Decline, Without Significant Tracking Error
10:20 PM • Trust Intelligence
Bernanke's Comments Boost The USD, Hurt The Euro
9:39 PM • Ralph Shell
Value Investors Should Not Overlook Volkswagen
9:29 PM • Labutes IR
Why The Dow Transports May Keep Rolling Over The S&P 500
8:25 PM • John Kozey
4 Ideas For Today's Low-Inflation Environment
7:38 PM • Russ Koesterich
Medtronic's Defibrillator Sales Show A Pulse With Encouraging Results
7:21 PM • Trefis
Consumer Loan Delinquencies Hit A New Low
6:59 PM • Calafia Beach Pundit
Bank Reserves: A Hot Potato
6:59 PM • Bob McTeer
Will It Be Inflation Or Deflation? The Answer May Surprise You
6:54 PM • Michael T. Snyder
Wall Street Strategist Year-End S&P 500 Price Targets
6:53 PM • Bespoke Investment Group
A Dole Of Doves To Send U.S. Economy Into Outer Space
6:53 PM • Pater Tenebrarum
Real Estate Mortgages - What Happened To Risk?
6:48 PM • Pater Tenebrarum
MLPs With Lower Leverage May Fare Better As Tapering Begins And Rates Rise
6:37 PM • Richard Shaw

More Latest Articles »